H.I.G. Capital

H.I.G. Capital is a Miami-headquartered global alternative investment firm with one of the most active middle-market healthcare practices, deploying capital across care delivery and tech-enabled services. The firm runs a broad set of strategies, including buyout, growth, and credit. AI is not a dedicated thesis, but H.I.G.’s scale means it can support tech-enabled platforms with operational depth. Specific AUM detail is not in the source data, though the firm is one of the larger global middle-market sponsors.

Check sizes are $25M+ at the growth/buyout stage, with deal sizes scaling significantly higher in larger transactions. Geographic deployment is global, with strong North American and European presence. Specific portfolio companies are not listed in the source data. Diligence is rigorous and operationally focused, with strong emphasis on EBITDA quality and value-creation playbooks.

For most physician AI founders, H.I.G. is relevant only late in the company’s journey. The right profile is a CEO running a scaled healthcare services or tech-enabled platform with established profitability. Pre-revenue or early-ARR founders should not prioritize H.I.G. The firm is best approached when the business is ready for a meaningful control transaction or large minority growth round.